![Richard Geary](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Geary
Direktor/Vorstandsmitglied bei
Oligonucleotide Therapeutics Society, Inc.
Vermögen: 5 Mio $ am 31.05.2026
Profil
Richard S.
Geary is currently Director at Oligonucleotide Therapeutics Society, Inc. Formerly, Dr. Geary was Vice President-Preclinical Development at Ionis Pharmaceuticals, Inc. from 2003 to 2008 and worked at Southwest Research Institute as Senior Research Scientist.
Education includes undergraduate studies at Texas A&M University and a doctorate from The University of Texas at Austin conferred in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 59’657 ( 0.04% ) | 5 Mio $ | 31.05.2026 |
Aktive Positionen von Richard Geary
| Unternehmen | Position | Beginn |
|---|---|---|
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Richard Geary
| Unternehmen | Position | Ende |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2026 |
Southwest Research Institute
 Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Richard Geary
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southwest Research Institute
Southwest Research Institute Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Commercial Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
